SIWA Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $6.37M

SIWA Therapeutics General Information

Description

Operator of a pre-clinical stage research entity intended to emphasize a monoclonal antibody that targets and destroys cancerous cells. The company's humanized monoclonal antibody selectively targets both senescent cells and cancer cells for destruction by the immune system, enabling clients to access cancer therapy which reduces cancer cells as well as the senescent cells surrounding the cancer cells in the tumor microenvironment that stimulate, feed and protect them.

Contact Information

Website
www.siwatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 East Randolph Street
  • Suite 705
  • Chicago, IL 60601
  • United States
+1 (312) 000-0000
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 400 East Randolph Street
  • Suite 705
  • Chicago, IL 60601
  • United States
+1 (312) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SIWA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 25-Mar-2020 $6.37M 000 Completed Pre-Clinical Trials
2. Seed Round 22-May-2017 00.000 00.000 Completed Pre-Clinical Trials
1. Capitalization 01-Jan-2011 Completed Startup
To view SIWA Therapeutics’s complete valuation and funding history, request access »

SIWA Therapeutics Patents

  • 130

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 83

    Granted

  • 35

    Pending

  • 000

    Expiring in next 12 mo

SIWA Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3229602-A1 Methods and compositions for treating fibrotic diseases Pending 20-Aug-2021 000000000
EP-4388016-A1 Methods and compositions for treating fibrotic diseases Pending 20-Aug-2021 000000000
US-20240000930-A1 Methods and compositions for treating kidney diseases Pending 09-Dec-2020 00000000000
CA-3177449-A1 Methods of treating infections Pending 01-May-2020 0000000000
EP-4143238-A1 Methods of treating infections Pending 01-May-2020 A61K39/395
To view SIWA Therapeutics’s complete patent history, request access »

SIWA Therapeutics Executive Team (3)

Name Title Board Seat
Lewis Gruber Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
Misty Gruber JD Co-Founder, Chief Administrative Officer & Board Member
Gabriela Rossi Ph.D Chief Research Officer
To view SIWA Therapeutics’s complete executive team members history, request access »

SIWA Therapeutics Board Members (4)

Name Representing Role Since
Alex Kormushoff Self Board Member 000 0000
James Alvarez Self Board Member 000 0000
John Peters III SIWA Therapeutics Chairman 000 0000
Misty Gruber JD SIWA Therapeutics Co-Founder, Chief Administrative Officer & Board Member 000 0000
To view SIWA Therapeutics’s complete board members history, request access »

SIWA Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

SIWA Therapeutics FAQs

  • When was SIWA Therapeutics founded?

    SIWA Therapeutics was founded in 2006.

  • Who is the founder of SIWA Therapeutics?

    Lewis Gruber and Misty Gruber JD are the founders of SIWA Therapeutics.

  • Who is the CEO of SIWA Therapeutics?

    Lewis Gruber is the CEO of SIWA Therapeutics.

  • Where is SIWA Therapeutics headquartered?

    SIWA Therapeutics is headquartered in Chicago, IL.

  • What is the size of SIWA Therapeutics?

    SIWA Therapeutics has 9 total employees.

  • What industry is SIWA Therapeutics in?

    SIWA Therapeutics’s primary industry is Biotechnology.

  • Is SIWA Therapeutics a private or public company?

    SIWA Therapeutics is a Private company.

  • What is SIWA Therapeutics’s current revenue?

    The current revenue for SIWA Therapeutics is 000000.

  • How much funding has SIWA Therapeutics raised over time?

    SIWA Therapeutics has raised $8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »